Clinical trial
An Exploration of the Impact of Emicizumab on the Lives of People With Haemophilia and Inhibitors and Their Families
NCT04723693 is registered in ClinicalTrials.gov with Haemnet as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Exploration of the Impact of Emicizumab on the Lives of People With Haemophilia and Inhibitors and Their Families
- Lead sponsor
- Haemnet
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2020
- Completion date
- January 31, 2021
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hemophilia a with inhibitor